Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Re: question re comt inhibitors
On Sat, 23 Oct 1999 03:56:26 -0400 janet paterson <janet313@xxxxxxxxxxx> writes: >hi all > >after reviewing the pmid abstracts on comt inhibitors >i started mulling > >i hadn't realized >that tolcapone crosses the blood brain barrier >while entacapone doesn't > >if the work that this class of med does >[saving lovely levodopa from arterial ambush by those vile venous comt >conspirators] >is done in the bloodstream prior to arrival at the brain station >why would either of them have to cross the blood brain barrier? >anyway? Catechol O'methyl Transferase - or COMT - is ALSO inside the brain, as far as I know. SO that is why I am taking tolcapone (Tasmar)- since I want both sides of the "blood-brain barrier" to be cleared of COMT. My question is: is entacapone as effective, less effective, or more effective than tolcapone?!! > >just a late nite thote about cone pone > >janet > >janet paterson >52 now / 41 dx / 37 onset >613 256 8340 po box 171 almonte ontario canada K0A 1A0 >a new voice: <> ><janet313@xxxxxxxxxxx> ^^^^^^ WARM GREETINGS FROM ^^^^^^^^^^^^ :-) Ivan Suzman 49/39/36 cureit@xxxxxxxx :-) Portland, Maine land of lighthouses pouring rain, 52 deg. F :-) ********************************************************************
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance